// App-Quantinova.ai

: Sustained Complement C1s Inhibition with Sutimlimab in Patients with Cold Agglutinin Disease Results in Continued Efficacy during Part B of the Randomized Placebo-Controlled Phase 3 Cadenza Study (NCT03347422)

Researchers

Presenter

  • Alexander Roeth

Principal Investigators

  • Wilma Barcellini

  • Shirley D'Sa

  • Bernd Jilma

  • Marc Michel

  • Ilene C. Weitz

  • Masaki Yamaguchi

  • Jun-ichi Nishimura

  • Josephine M.I. Vos

  • Joan Cid

  • Michael Storek

  • Nancy Wong

  • Ronnie Yoo

  • Jennifer Wang

  • Deepthi Vagge

  • MAREK WARDECKI

  • Frank Shafer

  • Michelle Lee

  • Catherine M. Broome

Medical Centers

  • UCLH Centre for Waldenström's Macroglobulinemia and Related Conditions, University College London Hospitals NHS Foundation Trust, London, United Kingdom

  • Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, Essen, Germany

  • Apheresis & Cellular Therapy Unit, Department of Hemotherapy and Hemostasis, ICMHO, IDIBAPS, Hospital Clínic, Barcelona, Spain

  • Henri-Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, UPEC, Créteil, France

  • Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

  • Division of Hematology, MedStar Georgetown University Hospital, Washington, DC

  • Osaka University Graduate School of Medicine, Suita, Japan

  • Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy

  • Department of Research and Innovation, Haugesund Hospital, Haugesund, NOR

  • Ishikawa Prefectural Central Hospital, Kanazawa, Japan

  • Keck School of Medicine of USC, Los Angeles, CA

  • Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria

Locations

  • United Kingdom

  • Japan

  • Netherlands

  • Germany

  • United States

  • Italy

  • India

  • Spain

  • Norway

  • Poland

  • Austria

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Efficacy

  • Safety

  • Placebo Control

  • Pharmacodynamics

  • Controlled

Phase

  • III

Study Id's

  • NCT03347422

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved